PSMA8 Human

Proteasome Subunit Alpha Type 8 Human Recombinant
Shipped with Ice Packs
In Stock

Description

PSMA8 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 270 amino acids (1-250) and having a molecular mass of 30kDa.
PSMA8 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Proteasome subunit alpha type-8 (PSMA8), a member of the peptidase T1A family, is a multicatalytic proteinase complex known for its ability to cleave peptides with specific amino acids (Arg, Phe, Tyr, Leu, and Glu) adjacent to the leaving group at neutral or slightly basic pH. This complex exhibits ATP-dependent proteolytic activity, and the PSMA8 subunit is believed to be testis-specific.
Description
Recombinant PSMA8 Human, produced in E.coli, is a single, non-glycosylated polypeptide chain consisting of 270 amino acids (residues 1-250) with a molecular weight of 30kDa. This protein is fused to a 20 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile filtered.
Formulation
The PSMA8 solution is provided at a concentration of 0.5mg/ml in a buffer containing 20mM Tris-HCl (pH 8.0), 1mM DTT, 10% glycerol, and 0.1M NaCl.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 90% via SDS-PAGE analysis.
Synonyms
Proteasome subunit alpha type-7-like, PSMA8, PSMA7L.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MASRYDRAIT VFSPDGHLFQ VEYAQEAVKK GSTAVGIRGT NIVVLGVEKK SVAKLQDERT VRKICALDDH VCMAFAGLTA DARVVINRAR VECQSHKLTV EDPVTVEYIT RFIATLKQKY TQSNGRRPFG ISALIVGFDD DGISRLYQTD PSGTYHAWKA
NAIGRSAKTV REFLEKNYTE DAIASDSEAI KLAIKALLEV VQSGGKNIEL AIIRRNQPLK MFSAKEVELY VTEIEKEKEE AEKKKSKKSV.

Q&A

What is PSMA8 and how does it differ from other proteasomal subunits?

PSMA8 (α4s) is a testis-specific paralog of the α4 subunit (PSMA7) of the 20S proteasome. Unlike the ubiquitously expressed PSMA7, PSMA8 expression is almost exclusively restricted to the testis and specifically to cells undergoing meiosis. PSMA8 replaces PSMA7 in the spermatoproteasome, providing substrate specificity and heterogeneity to the proteasome complex in testicular tissue . Structurally, PSMA8 functions as a core subunit of the proteasome and enables the assembly of unique proteasome complexes that target specific proteins for degradation during spermatogenesis.

When and where is PSMA8 expressed during spermatogenesis?

PSMA8 expression begins at the pachytene stage of meiotic prophase I. In mouse models, PSMA8 protein is first detected around postnatal day 12 (P12), with expression increasing from P14 to P20 during the first wave of spermatogenesis . Subcellularly, PSMA8 localizes to the central region of the synaptonemal complex (SC), a zipper-like structure that holds homologous chromosome pairs together during meiotic prophase I. This localization is dependent on proper synapsis formation, as demonstrated by its altered localization in synapsis-deficient mice . PSMA8 is not expressed in spermatogonia, Leydig cells, or Sertoli cells, confirming its specific expression in meiotic cells.

How can researchers distinguish between PSMA7 and PSMA8 in experimental settings?

Distinguishing between PSMA7 and PSMA8 requires careful experimental design due to their structural similarity. Methods include:

  • Antibody selection: Using antibodies targeting the C-terminus of PSMA8, which differs from PSMA7. The search results mention a specific antibody against the PSMA8 C-terminus that can differentiate between these proteins in western blotting .

  • Temporal analysis: Examining expression at different developmental timepoints, as PSMA7 expression precedes meiosis (detectable at P8), while PSMA8 appears later (from P12 onwards) .

  • Cell-type specificity: Analyzing cell lines (spermatogonium GC1-spg, Leydig cell TM3, and Sertoli cell TM4 lines) which express PSMA7 but not PSMA8 .

  • Mass spectrometry: Employing proteomic approaches to identify specific peptides unique to each protein.

For immunofluorescence studies, researchers should note that some antibodies (like the R2 antibody mentioned in the search results) detect both PSMA7 and PSMA8, requiring additional validation methods to confirm specific localization .

What is the role of PSMA8 in meiotic progression?

PSMA8-associated proteasomes are essential for the degradation of meiotic proteins and the progression of meiosis I during spermatogenesis . Research using PSMA8-deficient mice demonstrates that while early meiotic events proceed normally, including synapsis/desynapsis and DNA double-strand break (DSB) repair, there is a significant accumulation of spermatocytes in metaphase I and II . This suggests that PSMA8 is critical for the metaphase-to-anaphase transition during meiotic divisions.

The mechanism appears to involve the regulated degradation of key meiotic proteins that must be removed for proper cell cycle progression. In PSMA8-deleted spermatocytes, meiotic proteins that are normally degraded at late prophase I, such as RAD51 and RPA1, remain stable . This failure in protein turnover likely contributes to the observed meiotic arrest and subsequent apoptosis of spermatocytes.

How does PSMA8 deficiency affect histone acetylation and chromatin remodeling?

PSMA8 deficiency leads to significant alterations in histone acetylation patterns during spermatogenesis:

  • Accumulation of acetylated histones: Loss of PSMA8 results in higher levels of various acetylated histones, including H2AK5ac, H3ac, pan-H4ac, and H4K16ac, with the most pronounced effects observed in late prophase I .

  • Persistence through meiotic divisions: While H2AK5ac and H3ac are typically not detected in late diakinesis and round spermatids, pan-H4ac and H4K16ac abnormally persist in metaphase I chromosomes, interkinesis nuclei, and round spermatids in PSMA8-deficient mice .

  • Failed histone replacement: PSMA8-deficient spermatids arrest before histone replacement can take place, as evidenced by the absence of H2AL2 (a transition histone essential for the first replacement of histones by TNP1 and TNP2) .

These findings suggest that PSMA8-containing proteasomes are involved in the acetylation-dependent degradation of histones, which is crucial for the histone-to-protamine transition during spermiogenesis.

What is the relationship between PSMA8 and the proteasome activator PA200?

PSMA8 and PA200 (PSME4) demonstrate a critical functional relationship:

  • Co-immunoprecipitation evidence: PSMA8 co-immunoprecipitates with PA200, indicating a physical interaction between these proteins .

  • Dependency relationship: PSMA8 is necessary for or promotes the assembly of PA200 to the core particle (CP) of the proteasome. In PSMA8-deficient mice, PA200 fails to localize to the axial elements of spermatocytes and is not detectable by mass spectrometry analysis of PSMA7/8 immunoprecipitation .

  • Functional implications: PA200 is a proteasome activator that stimulates protein degradation independently of ubiquitin and plays a main role in acetylation-dependent degradation of somatic core histones during DNA repair and spermiogenesis . The failure of PA200 assembly in PSMA8-deficient mice likely contributes to the observed defects in histone degradation and subsequent chromatin remodeling.

This interaction represents a specialized mechanism for proteasomal regulation during spermatogenesis that differs from ubiquitin-dependent degradation pathways common in somatic cells.

What are the most effective animal models for studying PSMA8 function?

Based on the search results, mouse models have proven valuable for PSMA8 research:

  • CRISPR/Cas9-generated knockout mice: Targeted mutation in exon 1-intron 1 of the murine Psma8 gene has been successfully employed to generate PSMA8-deficient mice . This approach provides a complete null allele, allowing the study of PSMA8's role in vivo.

  • Synapsis-deficient mouse models: Models with mutations in genes affecting synapsis (e.g., Rec8 and Six6os1) have been used to study the dependency of PSMA8 localization on synaptonemal complex assembly . These models offer insights into the relationship between chromosome synapsis and PSMA8 function.

  • In vivo electroporation approach: The search results mention successful validation of PSMA8 localization through in vivo electroporation of an expression plasmid encoding GFP-PSMA8 in the testis , providing a method for studying protein localization in live tissue.

When designing experiments with these models, researchers should consider:

  • The male-specific infertility phenotype (females remain fertile)

  • The timing of the first wave of spermatogenesis for developmental studies

  • The availability of appropriate controls, including heterozygous animals

What techniques are most informative for analyzing PSMA8 function in spermatogenesis?

Several complementary techniques have proven valuable for PSMA8 research:

Histological and Cytological Approaches:

  • Histological analysis of seminiferous tubules at different epithelial stages

  • Immunofluorescence on chromosome spreads for precise staging of spermatocytes

  • TUNEL and Caspase-3 staining to assess apoptosis

  • PAS staining to evaluate acrosome formation

Biochemical Approaches:

  • Western blotting with specific antibodies against PSMA8 C-terminus

  • Proteasome activity assays measuring chymotrypsin-like, caspase-like, and trypsin-like activities

  • Co-immunoprecipitation coupled with mass spectrometry to identify interacting proteins

Flow Cytometry:

  • FACs analysis of whole cells from seminiferous tubules to quantify haploid compartments

When selecting methods, researchers should consider combining multiple approaches to gain comprehensive insights into both structural and functional aspects of PSMA8 biology.

How can proteasomal activity be accurately measured in PSMA8 research?

Measuring proteasomal activity in PSMA8 research requires careful consideration of several factors:

  • Standard fluorogenic assays: The search results describe measuring three distinct proteolytic activities:

    • Chymotrypsin-like activity (corresponding to the catalytic subunit β1)

    • Caspase-like activity (corresponding to β5)

    • Trypsin-like activity (β3)

  • Activation conditions: Assays should be performed both in the presence and absence of SDS (which activates the proteasome) to distinguish between latent and active proteasome populations.

  • Tissue-specific considerations: When working with testis extracts, the presence of PSMA7-dependent core particles may mask changes in PSMA8-specific activity . Therefore, researchers should consider additional approaches to isolate PSMA8-specific effects.

  • Complementary approaches: Activity measurements should be complemented with proteomic analysis to determine the abundance and composition of proteasome complexes.

When interpreting results, researchers should note that global proteasome activity may not show dramatic changes even when PSMA8 is absent, as observed in the search results where only trypsin-like activity showed a modest reduction in PSMA8-deficient testis extracts .

How might PSMA8 research inform our understanding of male infertility?

PSMA8 research has significant implications for understanding male infertility for several reasons:

  • Phenotypic relevance: PSMA8-deficient male mice are completely infertile while exhibiting no other somatic abnormalities , suggesting that PSMA8 mutations could be responsible for unexplained cases of male-specific infertility in humans.

  • Mechanistic insights: The research reveals a precise mechanism involving failure of meiotic protein degradation and subsequent metaphase arrest , which may represent a novel category of meiotic defects leading to infertility.

  • Diagnostic potential: Understanding PSMA8's role could lead to the development of diagnostic approaches for specific types of male infertility, particularly those characterized by meiotic arrest.

Future research directions might include:

  • Screening infertile men for PSMA8 mutations or expression abnormalities

  • Investigating whether PSMA8 function is affected by environmental factors or other genetic variations

  • Exploring whether pharmacological modulation of related proteasomal pathways could have therapeutic potential

What is known about PSMA8 interaction networks and how can they be studied?

The search results indicate that PSMA8 interacts with several key meiotic proteins:

  • Known interactors: PSMA8 has been shown to interact with proteins including SYCP3, SYCP1, CDK1, and TRIP13, as well as acetylated histones . These proteins show altered proteostasis in PSMA8-deficient mice.

  • Proteasome activator: PA200 (PSME4) co-immunoprecipitates with PSMA8 and requires PSMA8 for proper localization to axial elements .

To study these interaction networks, researchers have successfully employed:

Methodological approaches:

  • Co-immunoprecipitation coupled with mass spectrometry (a proteomic approach mentioned in the search results)

  • Analysis of protein persistence/degradation in knockout models

  • Localization studies using immunofluorescence

Future investigations could expand on these findings by:

  • Using proximity labeling techniques (BioID, APEX) to identify additional transient interactors

  • Applying single-cell proteomics to understand cell-type specific interactions

  • Employing structural biology approaches to determine the molecular basis of these interactions

  • Developing in vitro reconstitution systems to study the biochemical properties of PSMA8-containing proteasomes

What challenges exist in translating PSMA8 findings from mouse models to human applications?

While mouse models have provided valuable insights into PSMA8 function, several challenges exist in translating these findings to humans:

  • Species differences: Though the proteasome system is highly conserved, there may be differences in the regulation, expression patterns, or interacting proteins between mice and humans that could affect the relevance of specific findings.

  • Genetic redundancy: The search results focus on complete knockout models , but humans with partial reductions in PSMA8 function might show different phenotypes due to compensatory mechanisms.

  • Environmental influences: Human fertility is affected by numerous environmental and lifestyle factors that are not typically accounted for in laboratory mouse models.

  • Technical limitations: Obtaining human testicular samples at comparable stages to those studied in mice presents ethical and practical challenges.

Researchers addressing these challenges might consider:

  • Studying PSMA8 in human testicular samples when available through biobanks or from patients undergoing procedures for other clinical reasons

  • Using human cellular models such as induced pluripotent stem cells differentiated toward the germ cell lineage

  • Developing organoid models that better recapitulate human testicular physiology

  • Conducting comparative studies across multiple mammalian species to identify conserved mechanisms

What are the critical controls needed when studying PSMA8 in experimental systems?

When designing PSMA8 research, several critical controls should be implemented:

  • Antibody validation:

    • Use both PSMA8-specific antibodies (e.g., against the C-terminus) and antibodies recognizing both PSMA7/8

    • Include PSMA8-deficient samples as negative controls

    • Use cell lines known to express only PSMA7 (like GC1-spg, TM3, TM4) as specificity controls

  • Developmental timing controls:

    • Include samples from multiple timepoints during the first wave of spermatogenesis (P8, P12, P14, P20)

    • Compare adult versus juvenile tissues

  • Genetic controls:

    • Use proper littermate controls when working with knockout models

    • Consider heterozygous animals to assess gene dosage effects

    • When studying localization, include synapsis-deficient models as controls for dependency relationships

  • Functional validation:

    • When measuring proteasome activity, include reactions with and without SDS activation

    • Use known proteasome inhibitors as controls in activity assays

Implementing these controls will help distinguish PSMA8-specific effects from those related to general proteasome function or other confounding factors.

How should researchers interpret changes in histone acetylation patterns in PSMA8 studies?

Interpreting histone acetylation changes in PSMA8 studies requires consideration of several factors:

  • Cell stage specificity:

    • Different acetylation marks show distinct patterns across meiotic stages

    • H2AK5ac and H3ac are normally absent in late diakinesis and round spermatids

    • H4ac and H4K16ac typically persist longer through metaphase I, interkinesis, and early round spermatids

  • Quantification approaches:

    • The search results indicate that chromosome spreads with immunofluorescence provide more precise staging and quantitation than peroxidase immunostaining of testis sections

    • Relative fluorescence intensity should be measured across multiple cells and experimental replicates

  • Mechanistic considerations:

    • Increased acetylation may reflect failed degradation rather than increased acetylation activity

    • The relationship between PSMA8 and PA200 suggests a direct mechanistic link to histone degradation

  • Biological significance:

    • H4K16 acetylation specifically plays a pivotal role in the initiation of histone displacement and chromatin ultracondensation

    • Different acetylation marks may affect distinct aspects of chromatin remodeling

When reporting acetylation changes, researchers should clearly specify the particular histone modification, the cell type/stage being examined, and the quantification method used.

What are the advantages and limitations of different proteomic approaches for studying PSMA8?

The search results mention using co-immunoprecipitation coupled with mass spectrometry to identify PSMA8-interacting proteins . This approach has specific advantages and limitations that researchers should consider:

Advantages:

  • Identifies physiologically relevant protein complexes

  • Can discover novel, unexpected interactions

  • Provides a systems-level view of PSMA8 function

  • Can detect both stable and transient interactions depending on experimental conditions

Limitations:

  • May miss low-abundance interactors

  • Requires careful validation to exclude false positives

  • Antibody specificity issues (between PSMA7 and PSMA8) may complicate interpretation

  • May not distinguish direct from indirect interactions

Complementary approaches to consider:

  • Proximity labeling methods (BioID, APEX) to capture transient interactions

  • Crosslinking mass spectrometry to identify direct protein-protein contacts

  • Targeted proteomics (MRM/PRM) for quantitative analysis of specific interactions

  • Comparative proteomics of whole testis lysates from wild-type versus PSMA8-deficient mice

When designing proteomic experiments, researchers should consider the specific biological question being addressed and select the approach that best balances depth of coverage, specificity, and physiological relevance.

Product Science Overview

Introduction

Proteasome Subunit Alpha Type 8, also known as PSMA8, is a protein encoded by the PSMA8 gene in humans. This protein is a component of the proteasome, a large protein complex responsible for degrading unneeded or damaged proteins by proteolysis, a chemical reaction that breaks peptide bonds. The proteasome plays a crucial role in maintaining cellular homeostasis by regulating the concentration of specific proteins and degrading misfolded proteins.

Structure and Function

PSMA8 is a part of the 20S core proteasome complex, which is composed of 28 subunits arranged in four stacked rings. The outer two rings consist of seven alpha subunits, including PSMA8, while the inner two rings consist of seven beta subunits. The alpha subunits form a gate that controls the entry of substrates into the proteolytic chamber formed by the beta subunits.

PSMA8 is specifically expressed in the testis and is a component of the spermatoproteasome, a specialized form of the proteasome found in spermatogenic cells. The spermatoproteasome promotes the acetylation-dependent degradation of histones, thereby participating actively in the exchange of histones during spermatogenesis .

Biological Significance

The proteasome, including PSMA8, is essential for various cellular processes, including the regulation of the cell cycle, modulation of various signaling pathways, and the removal of damaged or misfolded proteins. In the context of spermatogenesis, PSMA8 is required for the degradation of meiotic proteins RAD51 and RPA1 at late prophase I and the progression of meiosis I . It localizes to the synaptonemal complex, a ‘zipper’-like structure that holds homologous chromosome pairs in synapsis during meiotic prophase I .

Recombinant PSMA8

Recombinant human PSMA8 is produced using recombinant DNA technology, where the PSMA8 gene is cloned and expressed in a suitable host system, such as Escherichia coli. The recombinant protein is then purified to high levels of purity, making it suitable for various applications, including structural and functional studies, as well as high-throughput screening assays .

Applications

Recombinant PSMA8 is used in research to study the structure and function of the proteasome, particularly in the context of spermatogenesis. It is also used in drug discovery and development, where it can be employed in high-throughput screening assays to identify potential inhibitors or modulators of the proteasome. Additionally, recombinant PSMA8 can be used in biochemical assays to investigate the mechanisms of protein degradation and the role of the proteasome in various cellular processes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.